FindTrial
Sign In

Use of a Novel Surgical Assist Device for Total Abdominal Fasciotomy in the Treatment of Retroperitoneal Liposarcoma

Using a new surgical auxiliary frame through Total Abdominal Fascial Compartment Resection treat retroperitoneal Liposarcoma and analyze its recurrence factors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109978
Enrollment
Unknown
Registered
2025-09-28
Start date
2024-12-12
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retroperitoneal Liposarcoma

Interventions

Abdominal Fascial Compartment Resection:Total Abdominal Fasciotomy
Standard Surgery Control Group:Standard Surgery Control Group

Sponsors

Ansteel Group General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.All patients underwent surgery at least once; 2.No contraindications to conventional surgery; 3.No distant metastasis of the tumor.

Exclusion criteria

Exclusion criteria: 1.Received other radiotherapy, chemotherapy, and/or targeted therapy; 2.Concurrent with other types of tumors; 3.Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Overall survival (OS);postoperation Complications ratio;Recurrence ratio;Progression-Free Survival, PFS;Postoperative mortality;—

Secondary

MeasureTime frame
Operation time;Histopathology,;tumor size,;tumor staging;Types and severity of postoperative complications;—

Countries

China

Contacts

Public ContactJia Wenliu

Ansteel Group General Hospital

Dlykdxljw@sina.com+86 412 6706304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026